Abstract
Endogenous substance such as nucleotide as a drug carrier has been proposed as a novel drug delivery system. The nucleotide guanosine-5′-monophosphate (GMP) is used to transport an anticancer drug pemetrexed disodium heptahydrate (PMX) via specific base pairing. The endogenous nature of GMP helps to avoid biocompatibility issues that are generally accompanied with nanocarriers including cytotoxicity, immunogenicity and blood compatibility. Furthermore, the low-molecular weight of the GMP nucleotide carrier significantly boosts the drug loading capacity compared to traditional liposomes and high-molecular weight carriers. Hydrogen-bonding interaction between the carrier and drug realizes the controlled release of loaded drug, and also facilitates large scale manufacture since no additional chemical synthesis is required. More importantly, in vivo experiments reveal that the base-paired GMP:PMX nanovesicles improve the target specificity and pharmacokinetic properties of PMX, and exhibit remarkably enhanced anticancer abilities compared to standalone PMX without any carriers. We envision that this strategy could be extended to other endogenous substances and drugs bearing functional groups capable of specific interaction, and promote the construction of drug delivery systems with inherent biocompatibility, enhanced drug delivery efficacy, and a simplified preparation method.
Similar content being viewed by others
References
Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. Proc Natl Acad Sci USA, 2002, 99: 12617–12621
Barenholz YC. J Control Release, 2012, 160: 117–134
Li M, Luo Z, Zhao Y. Sci China Chem, 2018, 61: 1214–1226
Mura S, Nicolas J, Couvreur P. Nat Mater, 2013, 12: 991–1003
Chen H, Gu Z, An H, Chen C, Chen J, Cui R, Chen S, Chen W, Chen X, Chen X, Chen Z, Ding B, Dong Q, Fan Q, Fu T, Hou D, Jiang Q, Ke H, Jiang X, Liu G, Li S, Li T, Liu Z, Nie G, Ovais M, Pang D, Qiu N, Shen Y, Tian H, Wang C, Wang H, Wang Z, Xu H, Xu JF, Yang X, Zhu S, Zheng X, Zhang X, Zhao Y, Tan W, Zhang X, Zhao Y. Sci China Chem, 2018, 61: 1503–1552
Allen TM, Cullis PR. Science, 2004, 303: 1818–1822
Brigger I, Dubernet C, Couvreur P. Adv Drug Deliver Rev, 2002, 54: 631–651
Farokhzad OC, Langer R. ACS Nano, 2009, 3: 16–20
Ganta S, Devalapally H, Shahiwala A, Amiji M. J Control Release, 2008, 126: 187–204
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nat Nanotech, 2007, 2: 751–760
Wang D, Tu C, Su Y, Zhang C, Greiser U, Zhu X, Yan D, Wang W. Chem Sci, 2015, 6: 3775–3787
Allen TM, Cullis PR. Adv Drug Deliver Rev, 2013, 65: 36–48
Pattni BS, Chupin VV, Torchilin VP. Chem Rev, 2015, 115: 10938–10966
Cao Z, Tong R, Mishra A, Xu W, Wong GCL, Cheng J, Lu Y. Angew Chem Int Ed, 2009, 48: 6494–6498
Liu Z, Robinson JT, Sun X, Dai H. J Am Chem Soc, 2008, 130: 10876–10877
Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P. Chem Soc Rev, 2013, 42: 1147–1235
Elsabahy M, Wooley KL. Chem Soc Rev, 2012, 41: 2545–2561
Feng X, Ding J, Gref R, Chen X. Chin J Polym Sci, 2017, 35: 693–699
Huang Y, Qin J, Wang J, Yan G, Wang X, Tang R. Sci China Chem, 2018, 61: 1447–1459
Zhou D, Cutlar L, Gao Y, Wang W, O’Keeffe-Ahern J, McMahon S, Duarte B, Larcher F, Rodriguez BJ, Greiser U, Wang W. Sci Adv, 2016, 2: e1600102
Zhou D, Gao Y, AS, Xu Q, Meng Z, Greiser U, Wang W. ACS Macro Lett, 2016, 5: 1266–1272
Li Z, Yu L, Yang T, Chen Y. Sci China Chem, 2018, 61: 1243–1260
Yang L, Zhang X, Ye M, Jiang J, Yang R, Fu T, Chen Y, Wang K, Liu C, Tan W. Adv Drug Deliver Rev, 2011, 63: 1361–1370
Rampersaud S, Fang J, Wei Z, Fabijanic K, Silver S, Jaikaran T, Ruiz Y, Houssou M, Yin Z, Zheng S, Hashimoto A, Hoshino A, Lyden D, Mahajan S, Matsui H. Nano Lett, 2016, 16: 7357–7363
Li J, Qiu L, Xie S, Zhang J, Zhang L, Liu H, Li J, Zhang X, Tan W. Sci China Chem, 2018, 61: 497–504
Yu G, Zhao X, Zhou J, Mao Z, Huang X, Wang Z, Hua B, Liu Y, Zhang F, He Z, Jacobson O, Gao C, Wang W, Yu C, Zhu X, Huang F, Chen X. J Am Chem Soc, 2018, 140: 8005–8019
Sun Q, Radosz M, Shen Y. J Control Release, 2012, 164: 156–169
de Jong WH, Borm PJA. Int J Nanomed, 2008, 3: 133–149
Nel A, Xia T, Mädler L, Li N. Science, 2006, 311: 622–627
Sharifi S, Behzadi S, Laurent S, Laird Forrest M, Stroeve P, Mahmoudi M. Chem Soc Rev, 2012, 41: 2323–2343
Xu L, Yang J, Xue B, Zhang C, Shi L, Wu C, Su Y, Jin X, Liu Y, Zhu X. Biomaterials, 2017, 147: 1–13
Jain K, Mehra NK, Jain NK. CPD, 2015, 21: 4252–4261
Kratz F, Müller-Driver R, Hofmann I, Drevs J, Unger C. J Med Chem, 2000, 43: 1253–1256
Han YC, Huang X, Wang YL. Chin Sci Bull, 2016, 61: 3127–3136
Bath J, Turberfield AJ. Nat Nanotech, 2007, 2: 275–284
Keefe AD, Pai S, Ellington A. Nat Rev Drug Discov, 2010, 9: 537–550
Wu Z, Tang LJ, Zhang XB, Jiang JH, Tan W. ACS Nano, 2011, 5: 7696–7699
Prins LJ, Reinhoudt DN, Timmerman P. Angew Chem Int Ed, 2001, 40: 2382–2426
Huang P, Wang D, Su Y, Huang W, Zhou Y, Cui D, Zhu X, Yan D. J Am Chem Soc, 2014, 136: 11748–11756
Ando H, Kobayashi S, Abu Lila AS, Eldin NE, Kato C, Shimizu T, Ukawa M, Kawazoe K, Ishida T. J Control Release, 2015, 220: 29–36
Chen Y, Pang Y, Wu J, Su Y, Liu J, Wang R, Zhu B, Yao Y, Yan D, Zhu X, Chen Q. Langmuir, 2010, 26: 9011–9016
Liu Y, Yu C, Jin H, Jiang B, Zhu X, Zhou Y, Lu Z, Yan D. J Am Chem Soc, 2013, 135: 4765–4770
Reul R, Nguyen J, Kissel T. Biomaterials, 2009, 30: 5815–5824
Wang D, Lin J, Jia F, Tan X, Wang Y, Sun X, Cao X, Che F, Lu H, Gao X, Shimkonis JC, Nyoni Z, Lu X, Zhang K. Sci Adv, 2019, 5: eaav9322
Solomon B, Bunn Jr PA. Future Oncology, 2005, 1: 733–746
Hwang KE, Kim YS, Hwang YR, Kwon SJ, Park DS, Cha BK, Kim BR, Yoon KH, Jeong ET, Kim HR. Oncology Rep, 2015, 33: 2411–2419
Barreto JA, O’Malley W, Kubeil M, Graham B, Stephan H, Spiccia L. Adv Mater, 2011, 23: H18–H40
Wang D, Yu C, Xu L, Shi L, Tong G, Wu J, Liu H, Yan D, Zhu X. J Am Chem Soc, 2018, 140: 8797–8806
Acknowledgements
This work was supported by the Shanghai Municipal Government (18JC1410800) and the National Natural Science Foundation of China (51690151, 21774077). We would like to thank Prof. Yongfeng Zhou for helpful discussion on the structure of nanoparticles, Jieli Wu and Bona Dai for the help on NMRs, Jiaojian Yuan for the help on LC-MS, and Jiwen Qian for the help on animal experiments. We would also like to thank Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. for generous donation of pemetrexed disodium heptahydrate and useful information on cell screening.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest The authors declare that they have no conflict of interest.
Supporting Online Material
11426_2019_9614_MOESM1_ESM.docx
Endogenous nucleotide as drug carrier: base-paired guanosine-5’-monophosphate:pemetrexed vesicles with enhanced anticancer capability
Rights and permissions
About this article
Cite this article
Xu, L., Yu, C., Wang, D. et al. Endogenous nucleotide as drug carrier: base-paired guanosine-5′-monophosphate:pemetrexed vesicles with enhanced anticancer capability. Sci. China Chem. 63, 244–253 (2020). https://doi.org/10.1007/s11426-019-9614-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-019-9614-2